← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Nirmidas Biotech, Inc.
Palo Alto, CA
$1,930,189
Total funding
3
Grants
Funding over time
peak $997.4K · FY2015–18$1M$750K$500K$250K$0
'15
'16
'17
'18
Funding mix
By agency
NIH$1,930,189 · 3
By mechanism
R44$1,301,503 · 1
R21$421,713 · 1
R43$206,973 · 1
Investigators at Nirmidas Biotech, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Development of multiplexed autoantibody test on pGOLD platform for Diagnosis and Screening of Type 1 Diabetes$804,811
R44 · FY2018 · DK
Development of multiplexed autoantibody test on pGOLD platform for Diagnosis and Screening of Type 1 Diabetes$496,692
R44 · FY2017 · DK
A Nanoscale Plasmonic-Gold Platform for Specific Diagnosis of Zika and Differentiation from other Flavivirus Infections$229,113
R21 · FY2017 · AI
Development of a plasmonic-based multiplexed platform for Diagnosis and Screening of Type 1 Diabetes and related Auto-Immune Diseases$206,973
R43 · FY2015 · DK
A Nanoscale Plasmonic-Gold Platform for Specific Diagnosis of Zika and Differentiation from other Flavivirus Infections$192,600
R21 · FY2018 · AI